Rite-Aid
This article was originally published in The Tan Sheet
Executive Summary
Announces "major restructuring" on Jan. 7 that includes a cash self-tender offer for up to 22 mil. of Rite-Aid common shares (at $16-18.50 per share) that will begin Jan. 10; the planned sale of Rite-Aid's four non-drugstore businesses (Encore Books, ADAP, Concord Custom Cleaners and Sera Tec Biologicals); and the closing of "200 under-performing drugstores and elimination of other assets causing a pre-tax write-off of $149.2 mil." The 200 as- yet-unnamed drug stores will be closed "within the next six months," Rite-Aid said
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning